G
Geraldine S. Pinkus
Researcher at Brigham and Women's Hospital
Publications - 286
Citations - 29136
Geraldine S. Pinkus is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Lymphoma & Immunoperoxidase. The author has an hindex of 84, co-authored 278 publications receiving 27112 citations. Previous affiliations of Geraldine S. Pinkus include University of Texas MD Anderson Cancer Center & Montreal General Hospital.
Papers
More filters
Journal ArticleDOI
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype.
Maximiliano Ramia De Cap,Leo P Wu,German Pihan,Damodaran Narayanan,Elizabeth A. Morgan,Geraldine S. Pinkus,Paola Dal Cin,Stephanie N. Hurwitz,Adam Bagg,Sanjay S. Patel,Wayne Tam,Madhu M Ouseph,Jeffrey Gagan,Yazan F. Madanat,Alexa J. Siddon,Philipp W. Raess,Heesun J. Rogers,Carlos E. Bueso-Ramos,Rashmi Kanagal-Shamanna,Jason H. Kurzer,Daniel A. Arber,Robert P. Hasserjian,Olga K. Weinberg +22 more
TL;DR: In this article , complex karyotype (CK) is associated with adverse outcome in myeloid neoplasms (MN) with NPM1 mutation and NPM2 mutation.
Journal ArticleDOI
Autopsy findings from patients diagnosed with COVID-19 demonstrate unique morphological patterns in bone marrow and lymph node
Ali Aljabban,Mark G. Evans,Geoffrey Fell,Jack P Guccione,Robert Edwards,Geraldine S. Pinkus,Robert F. Padera,Olga Pozdnyakova,Annette S. Kim +8 more
TL;DR: In this paper , the identification of haemophagocytosis in bone marrow (BM) is recurrently identified in patients with severe COVID-19, and a limited number of case series have focused on lymphoid or haematopoietic tissues.
Journal ArticleDOI
Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
TL;DR: In this paper, the nuclear marker SOX4 is expressed in neoplastic dendritic cell neoplasm (BPDCN) and showed 100% sensitivity and 98% specificity in distinguishing BPDCN from reactive pDCs and other neoplasms.